Evidence map›Paper›PMID 31525222›Full record

ArticlePloS one2019

Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Côte d'Ivoire, West Africa: A cross-sectional study.

Mariam Mama Djima, Didier Koumavi Ekouevi, Jean-Pierre Gregoire, Boris Tchounga, Patrick Ahuatchi Coffie, Viet-Thi Tran, Franck Y Touré, Jocelyne Moisan

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariam Mama DjimaPACCI, CHU Treichville, Abidjan, Côte d'Ivoire.ORCID 0000-0001-9099-9417
Didier Koumavi EkoueviPACCI, CHU Treichville, Abidjan, Côte d'Ivoire.
Jean-Pierre GregoireFaculté de pharmacie, Université Laval, Québec, Canada.ORCID 0000-0002-1467-9750
Boris TchoungaPACCI, CHU Treichville, Abidjan, Côte d'Ivoire.
Patrick Ahuatchi CoffiePACCI, CHU Treichville, Abidjan, Côte d'Ivoire.
Viet-Thi TranPACCI, CHU Treichville, Abidjan, Côte d'Ivoire.ORCID 0000-0003-1863-6739
Franck Y TouréPACCI, CHU Treichville, Abidjan, Côte d'Ivoire.
Jocelyne MoisanFaculté de pharmacie, Université Laval, Québec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Côte d'Ivoire, people living with HIV (PLHIV) have free access to antiretroviral therapy (ART) and cotrimoxazole. Yet, they may use other medications to treat non-HIV diseases. Scarce data are available regarding the use of non-HIV medications in Africa. This study describes the use of non-HIV medications and identifies the factors associated with their use by PLHIV on ART in Côte d'Ivoire.

methodsA cross-sectional study was conducted in six HIV clinics in 2016. HIV-1-infected adults receiving ART for at least one year were eligible. A standardized questionnaire was used to collect demographics, HIV characteristics and medication use data. Associated factors were identified using a multivariate adjusted Poisson regression.

resultsA total of 1,458 participants (74% women) were enrolled. The median age was 44 years, and the median duration of ART was 81 months. A total of 696 (48%) participants reported having used at least one non-HIV medication. Among the 1,519 non-HIV medications used, 550 (36%) had not been prescribed and 397 (26%) were from the nervous system class. Individuals who were more likely to report the use of at least one non-HIV medication included those who had been treated in an Abidjan HIV clinic, had a high school education level, had a monthly income between 152 and 304 euros, had a poor perceived health status, had WHO advanced clinical stage, had used traditional medicine products and had not used cotrimoxazole.

conclusionAlmost half PLHIV on ART reported using non-HIV medication. Further research is needed to assess whether the use of non-HIV medication is appropriate given about a third of those medications are not being prescribed.

Indexed as

Acquired Immunodeficiency SyndromeAdultAgedAnti-HIV AgentsCote d'IvoireDrug UtilizationFemaleHumansMaleMiddle AgedPrescription DrugsSocioeconomic FactorsTrimethoprim, Sulfamethoxazole Drug CombinationAnti-HIV AgentsPrescription DrugsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID31525222
PMCPMC6746366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.